PHENYLEPHRINE HCL injection, solution

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Wirkstoff:

Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV)

Verfügbar ab:

Cantrell Drug Company

Verabreichungsweg:

INTRAVENOUS

Verschreibungstyp:

PRESCRIPTION DRUG

Berechtigungsstatus:

unapproved drug other

Fachinformation

PHENYLEPHRINE HCL - PHENYLEPHRINE HCL INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
PHENYLEPHRINE HCL 40 MG ADDED TO 0.9% SODIUM CHLORIDE 250 ML BAG
PHENYLEPHRINE HCL
phenylephrine hcl injection, solution
Cantrell Drug Company
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:52533-110
ROUTE OF ADMINISTRATION
INTRAVENOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PHENYLEPHRINE HYDRO CHLO RIDE (UNII: 0 4JA59 TNSJ) (Phenylephrine -
UNII:1WS29 7W6 MV)
Phe nyle phrine
Hydro c hlo ride
16 0 ug
in 1 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO DIUM CHLO RIDE (UNII: 451W47IQ8 X)
9 .0 56 mg in 1 mL
TRISO DIUM CITRATE DIHYDRATE (UNII: B22547B9 5K)
6 4 ug in 1 mL
SO DIUM METABISULFITE (UNII: 4VON5FNS3C)
32 ug in 1 mL
CITRIC ACID MO NO HYDRATE (UNII: 29 6 8 PHW8 QP)
14.6 ug in 1 mL
WATER (UNII: 0 59 QF0 KO0 R)
OTHER INGREDIENTS
INGREDIENT KIND
INGREDIENT NAME
QUANTITY
May co ntain
SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:52533-110 -18
250 mL in 1 BAG; Type 0 : No t a Co mbinatio n Pro duct
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 6 /30 /20 11
LABELER -
Cantrell Drug Company (035545763)
Revised: 8/2015